LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 91

Search options

  1. Article ; Online: Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.

    Shulman, Stanford T

    Journal of the Pediatric Infectious Diseases Society

    2020  Volume 9, Issue 3, Page(s) 285–286

    MeSH term(s) Betacoronavirus ; COVID-19 ; Child ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome/epidemiology ; Systemic Inflammatory Response Syndrome/virology ; United States/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-05-22
    Publishing country England
    Document type Editorial
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piaa062
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Fatal Arrhythmic Complications of Multisystemic Inflammatory Syndrome (MIS-C) in a Pediatric Patient.

    Oragui, Chika C / Dilibe, Arthur

    Cureus

    2024  Volume 16, Issue 5, Page(s) e60927

    Abstract: In 2019, the emergence of the coronavirus disease 2019 (COVID-19) virus triggered a global pandemic ... This syndrome was later classified as multisystem inflammatory syndrome in children (MIS-C) by the Pediatric ... syndrome affecting multiple organ systems emerged, sharing similarities with Kawasaki's disease ...

    Abstract In 2019, the emergence of the coronavirus disease 2019 (COVID-19) virus triggered a global pandemic, reminiscent of the magnitude witnessed during the flu pandemic of 1918. Initially, children often presented with either asymptomatic or mild upper respiratory tract infection symptoms. However, in the post-acute phase, a distinct syndrome affecting multiple organ systems emerged, sharing similarities with Kawasaki's disease. This syndrome was later classified as multisystem inflammatory syndrome in children (MIS-C) by the Pediatric Intensive Care Society in April 2020. Notably, cardiac manifestations and complications associated with COVID-19 constitute a significant source of morbidity and mortality, characterized by left ventricular dysfunction, cardiac conduction abnormalities, and arrhythmias. Although cases of arrhythmias with MIS-C are rare in the literature, we present a unique case involving a 14-year-old without known cardiac risk factors who presented with conduction abnormalities and fatal arrhythmias secondary to MIS-C.
    Language English
    Publishing date 2024-05-23
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.60927
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.

    Sun, Yi-Kan / Wang, Can / Lin, Pei-Quan / Hu, Lei / Ye, Jing / Gao, Zhi-Gang / Lin, Ru / Li, Hao-Min / Shu, Qiang / Huang, Li-Su / Tan, Lin-Hua

    World journal of pediatrics : WJP

    2024  Volume 20, Issue 4, Page(s) 307–324

    Abstract: Background: Coronavirus disease 2019 (COVID-19) tends to have mild presentations in children ... manifestations. Multisystem inflammatory syndrome in children (MIS-C), a potentially life-threatening immune ... mediated condition chronologically associated with COVID-19 exposure, denotes another scientific and ...

    Abstract Background: Coronavirus disease 2019 (COVID-19) tends to have mild presentations in children. However, severe and critical cases do arise in the pediatric population with debilitating systemic impacts and can be fatal at times, meriting further attention from clinicians. Meanwhile, the intricate interactions between the pathogen virulence factors and host defense mechanisms are believed to play indispensable roles in severe COVID-19 pathophysiology but remain incompletely understood.
    Data sources: A comprehensive literature review was conducted for pertinent publications by reviewers independently using the PubMed, Embase, and Wanfang databases. Searched keywords included "COVID-19 in children", "severe pediatric COVID-19", and "critical illness in children with COVID-19".
    Results: Risks of developing severe COVID-19 in children escalate with increasing numbers of co-morbidities and an unvaccinated status. Acute respiratory distress stress and necrotizing pneumonia are prominent pulmonary manifestations, while various forms of cardiovascular and neurological involvement may also be seen. Multiple immunological processes are implicated in the host response to COVID-19 including the type I interferon and inflammasome pathways, whose dysregulation in severe and critical diseases translates into adverse clinical manifestations. Multisystem inflammatory syndrome in children (MIS-C), a potentially life-threatening immune-mediated condition chronologically associated with COVID-19 exposure, denotes another scientific and clinical conundrum that exemplifies the complexity of pediatric immunity. Despite the considerable dissimilarities between the pediatric and adult immune systems, clinical trials dedicated to children are lacking and current management recommendations are largely adapted from adult guidelines.
    Conclusions: Severe pediatric COVID-19 can affect multiple organ systems. The dysregulated immune pathways in severe COVID-19 shape the disease course, epitomize the vast functional diversity of the pediatric immune system and highlight the immunophenotypical differences between children and adults. Consequently, further research may be warranted to adequately address them in pediatric-specific clinical practice guidelines.
    MeSH term(s) Humans ; COVID-19/immunology ; COVID-19/complications ; Child ; Systemic Inflammatory Response Syndrome/immunology ; Systemic Inflammatory Response Syndrome/physiopathology ; Severity of Illness Index
    Language English
    Publishing date 2024-02-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2236681-7
    ISSN 1867-0687 ; 1708-8569
    ISSN (online) 1867-0687
    ISSN 1708-8569
    DOI 10.1007/s12519-023-00790-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort.

    Ramamoorthy, Jaikumar Govindaswamy / Avinash, Anantharaj / Karunakar, Pediredla / Parale, Chinmay / Velayutham, Ramanathan / Sukumaran, Suresh Kumar / Balaguru, Sridhar / Parameswaran, Narayanan / M, Mugunthan / Dhodapkar, Rahul / Basu, Debdatta / Selvaraj, Raja / Satheesh, Santhosh / Biswal, Niranjan

    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

    2024  Volume 52, Issue 3, Page(s) 189–198

    Abstract: ... at admission, 1.5 months, and 3 months. Coronavirus Disease 2019 (COVID-19) antibody titers were assessed ... of patients who were tested, 88.9% tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS ... inflammatory syndrome in children (MIS-C). This study aimed to examine the recovery of affected cardiovascular ...

    Title translation Pediatrik Multisistem İnflamatuvar Sendrom Kohortunun Uzun Dönemli Ekokardiyografik İzlemi.
    Abstract Objective: Significant involvement of the cardiovascular system is known in multisystem inflammatory syndrome in children (MIS-C). This study aimed to examine the recovery of affected cardiovascular parameters over a medium-term follow-up.
    Methods: A cohort of 69 children was studied prospectively. Assessments of left ventricular (LV) function and coronary artery abnormalities (CAA) were conducted at admission, 1.5 months, and 3 months. Coronavirus Disease 2019 (COVID-19) antibody titers were assessed at these three time points. Echocardiographic and antibody parameters (rising/decreasing) were analyzed for correlation. Outcomes were assessed using logistic regression.
    Results: At admission, among the 78.2% of patients who were tested, 88.9% tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). A quarter of the patients had pericardial effusion, and half had valvulitis. Decreased ejection fraction, global circumferential strain (GCS), and global longitudinal strain (GLS) were seen in 54.4%, 68.6%, and 35.8% of patients, respectively. CAAs were observed in 27.78% of patients. Systolic dysfunction was significantly associated with older age. During follow-up, severe LV dysfunction normalized within 6-7 weeks, while mild to moderate dysfunction reached normalcy by two weeks. Both GCS and GLS reached normalcy within a median of two weeks. Diastolic parameters recovered by six weeks. Most small and moderate coronary aneurysms resolved, but a giant aneurysm in an infant remained large even after 15 months. Trends in antibodies and ejection fraction (EF) at three months were significantly correlated. Admission EF, GLS (at 6 weeks) and deceleration time (at 3 months) were significantly associated with intensive care unit (ICU) admission. The median segmental strain of the cohort remained low in certain segments at three months.
    Conclusion: Smaller CAAs resolve, whereas giant CAAs persist. EF and GLS are important predictors of Pediatric Intensive Care Unit (PICU) stay. The residual impairment of median segmental strain and persistent diastolic dysfunction at three months indicate the need for long-term follow-up.
    MeSH term(s) Infant ; Humans ; Child ; Follow-Up Studies ; Echocardiography ; COVID-19/diagnostic imaging ; COVID-19/complications ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome
    Language English
    Publishing date 2024-04-04
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 1215217-1
    ISSN 1308-4488 ; 1016-5169
    ISSN (online) 1308-4488
    ISSN 1016-5169
    DOI 10.5543/tkda.2023.60940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID 19 infection: Pediatric perspectives.

    Adeyinka, Adebayo / Bailey, Keneisha / Pierre, Louisdon / Kondamudi, Noah

    Journal of the American College of Emergency Physicians open

    2021  Volume 2, Issue 1, Page(s) e12375

    Abstract: ... Recently, a new entity associated with COVID-19 called multisystem inflammatory syndrome in children (MIS-C ... The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome ... coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, causing innumerable deaths and a massive ...

    Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, causing innumerable deaths and a massive economic catastrophe. Exposure to household members with confirmed COVID-19 is the most common source of infection among children. Children are just as likely as adults to get infected with SARS-CoV-2. Most children are asymptomatic and when symptoms occur, they are usually mild. Infants <12 months old are at a higher risk for severe or critical disease. COVID-19 is diagnosed the same way in pediatric population as adults by testing specimen obtained from upper respiratory tract for nucleic acid amplification test (NAAT) using reverse transcriptase viral polymerase chain reaction (RT-PCR). The common laboratory findings in hospitalized patient include leukopenia, lymphopenia, and increased levels of inflammatory markers. Chest X-ray findings are variable and computed tomography scans of the chest may show ground glass opacities similar to adults or non-specific findings. Prevention is the primary intervention strategy. Recently the U.S. Food and Drug Administration (FDA) has provided emergency authorization of the Pfizer-BioNTech COVID-19 vaccine and many other vaccine candidates are in the investigational stage. There is limited data in children on the use of antivirals, hydroxychloroquine, azithromycin, monoclonal antibody, and convalescent plasma. Oxygen therapy is required in hypoxic children (saturation <92%). Similar to adults, other measures to maintain oxygenation such as high flow nasal cannula, CPAP, or ventilatory support may be needed. Ventilatory management strategies should include use of low tidal volumes (5-6 cc/kg), high positive expiratory pressure, adequate sedation, paralysis, and prone positioning. Recently, a new entity associated with COVID-19 called multisystem inflammatory syndrome in children (MIS-C) has emerged. Clinical, laboratory, and epidemiological criteria are the basis for this diagnosis. Management options include ICU admission, steroids, intravenous gamma globulin, aspirin, anakinra, and anticoagulants. Vasoactive-inotropic score (VIS) is used to guide vasopressor support.
    Language English
    Publishing date 2021-01-29
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2688-1152
    ISSN (online) 2688-1152
    DOI 10.1002/emp2.12375
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Ocular manifestations of COVID-19 in the pediatric age group.

    Alnahdi, Muhannad A / Alkharashi, Maan

    European journal of ophthalmology

    2022  , Page(s) 11206721221116210

    Abstract: The coronavirus disease 2019 (COVID-19) is now known to be associated with several ocular ... in the new multisystem inflammatory syndrome in children (MIS-C), a novel entity associated by COVID-19 ... in the pediatric age group. We aim to outline the various pediatric ocular manifestations described ...

    Abstract The coronavirus disease 2019 (COVID-19) is now known to be associated with several ocular manifestations. The literature thoroughly discussed those that affect adults, with a lesser focus in the pediatric age group. We aim to outline the various pediatric ocular manifestations described in the literature. The manifestations may be divided into isolated events attributed to COVID-19 or occurring in the new multisystem inflammatory syndrome in children (MIS-C), a novel entity associated by COVID-19 infection. Ocular manifestations have virtually affected all ages. They manifested in neonates, infants, children, and adolescents. Episcleritis, conjunctivitis, optic neuritis, cranial nerve palsies, retinal vein occlusion, retinal vasculitis, retinal changes, orbital myositis, orbital cellulitis were reported in the literature with this emerging viral illness. Conjunctivitis was the most common ocular manifestation in MIS-C in nearly half of the patients. Other ocular manifestations in MIS-C were anterior uveitis, corneal epitheliopathy, optic neuritis, idiopathic intracranial hypertension, and retinitis. The clinical outcome was favorable, and children regain their visual ability with minimal or no deficits in most of the cases. Further follow-up may be warranted to better understand the long-term effects and visual prognosis.
    Language English
    Publishing date 2022-07-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1089461-5
    ISSN 1724-6016 ; 1120-6721
    ISSN (online) 1724-6016
    ISSN 1120-6721
    DOI 10.1177/11206721221116210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Severe acute respiratory syndrome coronavirus-2-related and imputable deaths in children: results from the French pediatric national registry.

    Lockhart-Bouron, Marguerite / Vanel, Noémie / Levy, Michael / Briant, Anaïs R / Javouhey, Etienne / Breinig, Sophie / Dina, Julia / Caseris, Marion / Angoulvant, François / Leteurtre, Stéphane / Recher, Morgan / Brossier, David W

    World journal of pediatrics : WJP

    2024  

    Abstract: ... inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1 ... Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible ... PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric ...

    Abstract Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for an important mortality rate worldwide. We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit (PICU). Secondary objectives were to identify risk factors for death.
    Methods: This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions (PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1, 2021, and August 31, 2022. Included patients were classified and compared according to their living status at the end of their PICU stay. Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care. The imputability of SARS-CoV-2 as the cause of death was classified into four categories: certain, very probable, possible, or unlikely, and was defined by any of the first three categories.
    Results: There were 948 patients included of which 43 died (4.5%). From this, 26 deaths (67%) could be attributed to SARS-CoV-2 infection, with an overall mortality rate of 2.8%. The imputability of death to SARS-CoV-2 was considered certain in only one case (0.1%). Deceased patients suffered more often from comorbidities, especially heart disease, neurological disorders, hematological disease, cancer, and obesity. None of the deceased patients were admitted for pediatric inflammatory multisystem syndrome (PIMS). Mortality risk factors were male gender, cardiac comorbidities, cancer, and acute respiratory distress syndrome.
    Conclusions: SARS-CoV-2 mortality in the French pediatric population was low. Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases, this imputability was considered certain in only one case.
    Language English
    Publishing date 2024-03-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2236681-7
    ISSN 1867-0687 ; 1708-8569
    ISSN (online) 1867-0687
    ISSN 1708-8569
    DOI 10.1007/s12519-023-00791-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective.

    Sethi, Sidharth Kumar / Rana, Abhyuday / Adnani, Harsha / McCulloch, Mignon / Alhasan, Khalid / Sultana, Azmeri / Safadi, Rama / Agrawal, Nirav / Raina, Rupesh

    Clinical kidney journal

    2021  Volume 14, Issue 9, Page(s) 2000–2011

    Abstract: ... morbidity and mortality. There are several reports of a direct viral tropism of coronavirus disease 2019 and ... The initial report of the multisystem inflammatory syndrome in children (MIS-C) was from the UK ... ranging from 10% to 46%. Kidney involvement following severe acute respiratory syndrome coronavirus 2 ...

    Abstract The initial report of the multisystem inflammatory syndrome in children (MIS-C) was from the UK in April 2020; since then, cases have been reported worldwide. Renal involvement has been seen commonly, ranging from 10% to 46%. Kidney involvement following severe acute respiratory syndrome coronavirus 2 infection in children with MIS-C is more common than initially thought and is associated with higher morbidity and mortality. There are several reports of a direct viral tropism of coronavirus disease 2019 and MIS-C-associated renal damage. This study's objective was to systematically review the current understanding of kidney involvement in children suffering from MIS-C. Based on our systemic literature search, 19 studies have either partially or fully discussed kidney involvement in MIS-C patients. Furthermore, we discuss the multifactorial pathogenesis contributing to acute kidney injury (AKI) development in MIS-C. The current review gives a pediatric nephrologist's perspective of the renal involvement in MIS-C, the incidence of AKI, the pathophysiology of AKI in MIS-C and the proposed therapeutic regimens available, including the need for kidney replacement therapy for a child with AKI associated with MIS-C. As the disease is rapidly evolving, more detailed clinical prospective studies are required to understand MIS-C and its role in AKI better.
    Language English
    Publishing date 2021-04-15
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2655800-2
    ISSN 2048-8513 ; 2048-8505
    ISSN (online) 2048-8513
    ISSN 2048-8505
    DOI 10.1093/ckj/sfab073
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.

    Sacco, Keith / Castagnoli, Riccardo / Vakkilainen, Svetlana / Liu, Can / Delmonte, Ottavia M / Oguz, Cihan / Kaplan, Ian M / Alehashemi, Sara / Burbelo, Peter D / Bhuyan, Farzana / de Jesus, Adriana A / Dobbs, Kerry / Rosen, Lindsey B / Cheng, Aristine / Shaw, Elana / Vakkilainen, Mikko S / Pala, Francesca / Lack, Justin / Zhang, Yu /
    Fink, Danielle L / Oikonomou, Vasileios / Snow, Andrew L / Dalgard, Clifton L / Chen, Jinguo / Sellers, Brian A / Montealegre Sanchez, Gina A / Barron, Karyl / Rey-Jurado, Emma / Vial, Cecilia / Poli, Maria Cecilia / Licari, Amelia / Montagna, Daniela / Marseglia, Gian Luigi / Licciardi, Francesco / Ramenghi, Ugo / Discepolo, Valentina / Lo Vecchio, Andrea / Guarino, Alfredo / Eisenstein, Eli M / Imberti, Luisa / Sottini, Alessandra / Biondi, Andrea / Mató, Sayonara / Gerstbacher, Dana / Truong, Meng / Stack, Michael A / Magliocco, Mary / Bosticardo, Marita / Kawai, Tomoki / Danielson, Jeffrey J / Hulett, Tyler / Askenazi, Manor / Hu, Shaohui / Cohen, Jeffrey I / Su, Helen C / Kuhns, Douglas B / Lionakis, Michail S / Snyder, Thomas M / Holland, Steven M / Goldbach-Mansky, Raphaela / Tsang, John S / Notarangelo, Luigi D

    Nature medicine

    2022  Volume 28, Issue 5, Page(s) 1050–1062

    Abstract: Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children ... infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem ... inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional ...

    Abstract Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers, proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n = 110) and MIS-C (n = 76), along with pediatric healthy controls (pHCs; n = 76). pCOVID-19 was characterized by robust type I interferon (IFN) responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy.
    MeSH term(s) COVID-19/complications ; COVID-19/genetics ; Child ; Humans ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome/genetics ; T-Lymphocytes
    Language English
    Publishing date 2022-02-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1220066-9
    ISSN 1546-170X ; 1078-8956
    ISSN (online) 1546-170X
    ISSN 1078-8956
    DOI 10.1038/s41591-022-01724-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top